社区
首页
集团介绍
社区
资讯
行情
学堂
TigerAI
登录
注册
LancetAeon
IP属地:未知
+关注
帖子 · 7
帖子 · 7
关注 · 0
关注 · 0
粉丝 · 0
粉丝 · 0
LancetAeon
LancetAeon
·
2021-07-29
Hdhdbdjxndkdmsns d end f f gbf
非常抱歉,此主贴已删除
看
1,923
回复
评论
点赞
1
编组 21备份 2
分享
举报
LancetAeon
LancetAeon
·
2021-07-22
Good thanks
非常抱歉,此主贴已删除
看
1,854
回复
1
点赞
点赞
编组 21备份 2
分享
举报
LancetAeon
LancetAeon
·
2021-07-22
I got morderna shot and got really sore back
Moderna Joins Top S&P 500 Firms as Stock Value Triples<blockquote>Moderna 加入标普500顶级公司行列,股票价值增加两倍</blockquote>
(Bloomberg) -- Moderna Inc. joined the S&P 500 on Wednesday as the index’s the best performing stock
Moderna Joins Top S&P 500 Firms as Stock Value Triples<blockquote>Moderna 加入标普500顶级公司行列,股票价值增加两倍</blockquote>
看
1,512
回复
2
点赞
4
编组 21备份 2
分享
举报
LancetAeon
LancetAeon
·
2021-07-21
I like reading variable article please it’s no good
非常抱歉,此主贴已删除
看
1,495
回复
评论
点赞
2
编组 21备份 2
分享
举报
LancetAeon
LancetAeon
·
2021-07-19
Thanks good great appreciates
非常抱歉,此主贴已删除
看
1,689
回复
评论
点赞
点赞
编组 21备份 2
分享
举报
LancetAeon
LancetAeon
·
2021-06-02
Don’t be like this . Too good
非常抱歉,此主贴已删除
看
2,503
回复
评论
点赞
点赞
编组 21备份 2
分享
举报
LancetAeon
LancetAeon
·
2021-06-02
Commenting here for comments
非常抱歉,此主贴已删除
看
1,740
回复
评论
点赞
1
编组 21备份 2
分享
举报
加载更多
暂无关注
热议股票
{"i18n":{"language":"zh_CN"},"isCurrentUser":false,"userPageInfo":{"id":"3585284420886130","uuid":"3585284420886130","gmtCreate":1622190396684,"gmtModify":1623999354757,"name":"LancetAeon","pinyin":"lancetaeon","introduction":"","introductionEn":"","signature":"","avatar":"https://static.tigerbbs.com/dee20d63780d522a952021ff6acccef1","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":0,"headSize":1,"tweetSize":7,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":0,"name":"","nameTw":"","represent":"","factor":"","iconColor":"","bgColor":""},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":null,"userBadges":[{"badgeId":"e50ce593bb40487ebfb542ca54f6a561-3","templateUuid":"e50ce593bb40487ebfb542ca54f6a561","name":"偶像虎友","description":"加入老虎社区1500天","bigImgUrl":"https://static.tigerbbs.com/8b40ae7da5bf081a1c84df14bf9e6367","smallImgUrl":"https://static.tigerbbs.com/f160eceddd7c284a8e1136557615cfad","grayImgUrl":"https://static.tigerbbs.com/11792805c468334a9b31c39f95a41c6a","redirectLinkEnabled":0,"redirectLinkType":null,"redirectLink":null,"redirectLinkValidityFrom":null,"redirectLinkValidityTo":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2026.04.25","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001,"isScarce":0,"effectConfig":null,"effectEnabled":0,"plateImgUrl":null,"plateColors":null,"validityTo":null,"validityToTimestamp":null,"wearingSort":0},{"badgeId":"35ec162348d5460f88c959321e554969-3","templateUuid":"35ec162348d5460f88c959321e554969","name":"传说交易员","description":"证券或期货账户累计交易次数达到300次","bigImgUrl":"https://static.tigerbbs.com/656db16598a0b8f21429e10d6c1cb033","smallImgUrl":"https://static.tigerbbs.com/03f10910d4dd9234f9b5702a3342193a","grayImgUrl":"https://static.tigerbbs.com/0c767e35268feb729d50d3fa9a386c5a","redirectLinkEnabled":0,"redirectLinkType":null,"redirectLink":null,"redirectLinkValidityFrom":null,"redirectLinkValidityTo":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2024.04.23","exceedPercentage":"93.13%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100,"isScarce":0,"effectConfig":null,"effectEnabled":0,"plateImgUrl":null,"plateColors":null,"validityTo":null,"validityToTimestamp":null,"wearingSort":0},{"badgeId":"976c19eed35f4cd78f17501c2e99ef37-1","templateUuid":"976c19eed35f4cd78f17501c2e99ef37","name":"博闻投资者","description":"累计交易超过10只正股","bigImgUrl":"https://static.tigerbbs.com/e74cc24115c4fbae6154ec1b1041bf47","smallImgUrl":"https://static.tigerbbs.com/d48265cbfd97c57f9048db29f22227b0","grayImgUrl":"https://static.tigerbbs.com/76c6d6898b073c77e1c537ebe9ac1c57","redirectLinkEnabled":0,"redirectLinkType":null,"redirectLink":null,"redirectLinkValidityFrom":null,"redirectLinkValidityTo":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2023.02.10","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1102,"isScarce":0,"effectConfig":null,"effectEnabled":0,"plateImgUrl":null,"plateColors":null,"validityTo":null,"validityToTimestamp":null,"wearingSort":0},{"badgeId":"228c86a078844d74991fff2b7ab2428d-3","templateUuid":"228c86a078844d74991fff2b7ab2428d","name":"投资合伙人虎","description":"证券账户累计交易金额达到100万美元","bigImgUrl":"https://static.tigerbbs.com/fbeac6bb240db7da8b972e5183d050ba","smallImgUrl":"https://static.tigerbbs.com/436cdf80292b99f0a992e78750ac4e3a","grayImgUrl":"https://static.tigerbbs.com/506a259a7b456f037592c3b23c779599","redirectLinkEnabled":0,"redirectLinkType":null,"redirectLink":null,"redirectLinkValidityFrom":null,"redirectLinkValidityTo":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.28","exceedPercentage":"93.57%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1101,"isScarce":0,"effectConfig":null,"effectEnabled":0,"plateImgUrl":null,"plateColors":null,"validityTo":null,"validityToTimestamp":null,"wearingSort":0},{"badgeId":"518b5610c3e8410da5cfad115e4b0f5a-1","templateUuid":"518b5610c3e8410da5cfad115e4b0f5a","name":"实盘交易者","description":"完成一笔实盘交易","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLinkType":null,"redirectLink":null,"redirectLinkValidityFrom":null,"redirectLinkValidityTo":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100,"isScarce":0,"effectConfig":null,"effectEnabled":0,"plateImgUrl":null,"plateColors":null,"validityTo":null,"validityToTimestamp":null,"wearingSort":0}],"userBadgeCount":5,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":12,"crmLevelSwitch":0,"location":"未知","starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"page":1,"watchlist":null,"tweetList":[{"id":808020538,"gmtCreate":1627545777624,"gmtModify":1633763942808,"author":{"id":"3585284420886130","authorId":"3585284420886130","name":"LancetAeon","avatar":"https://static.tigerbbs.com/dee20d63780d522a952021ff6acccef1","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3585284420886130","authorIdStr":"3585284420886130"},"themes":[],"title":"","htmlText":"Hdhdbdjxndkdmsns d end f f gbf","listText":"Hdhdbdjxndkdmsns d end f f gbf","text":"Hdhdbdjxndkdmsns d end f f gbf","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/808020538","repostId":"2155755908","repostType":4,"isVote":1,"tweetType":1,"viewCount":1923,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":172057518,"gmtCreate":1626923049134,"gmtModify":1633769688780,"author":{"id":"3585284420886130","authorId":"3585284420886130","name":"LancetAeon","avatar":"https://static.tigerbbs.com/dee20d63780d522a952021ff6acccef1","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3585284420886130","authorIdStr":"3585284420886130"},"themes":[],"title":"","htmlText":"Good thanks ","listText":"Good thanks ","text":"Good thanks","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/172057518","repostId":"2153640444","repostType":4,"isVote":1,"tweetType":1,"viewCount":1854,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":172057900,"gmtCreate":1626923018200,"gmtModify":1633769689025,"author":{"id":"3585284420886130","authorId":"3585284420886130","name":"LancetAeon","avatar":"https://static.tigerbbs.com/dee20d63780d522a952021ff6acccef1","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3585284420886130","authorIdStr":"3585284420886130"},"themes":[],"title":"","htmlText":"I got morderna shot and got really sore back","listText":"I got morderna shot and got really sore back","text":"I got morderna shot and got really sore back","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/172057900","repostId":"1105130573","repostType":4,"repost":{"id":"1105130573","kind":"news","pubTimestamp":1626921817,"share":"https://www.laohu8.com/m/news/1105130573?lang=zh_CN&edition=full","pubTime":"2021-07-22 10:43","market":"us","language":"en","title":"Moderna Joins Top S&P 500 Firms as Stock Value Triples<blockquote>Moderna 加入标普500顶级公司行列,股票价值增加两倍</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1105130573","media":"Bloomberg","summary":"(Bloomberg) -- Moderna Inc. joined the S&P 500 on Wednesday as the index’s the best performing stock","content":"<p>(Bloomberg) -- Moderna Inc. joined the S&P 500 on Wednesday as the index’s the best performing stock this year -- by a mile.</p><p><blockquote>(彭博社) -- Moderna Inc. 周三加入标普500,成为该指数今年表现最好的股票。</blockquote></p><p> The move caps the drugmaker’s transformation from an early-stage biotech to a vaccine maker supplying Covid shots to the world. With a gain of just over 207% so far in 2021, Moderna’s share performance tops the index’s existing leader, L Brands Inc., which has risen about 104%.</p><p><blockquote>此举标志着该制药商从一家早期生物技术公司向一家向全球供应 Covid 疫苗的疫苗制造商的转型。2021 年迄今为止,Moderna 的股价涨幅略高于 207%,超过了该指数的现有领头羊 L Brands Inc.</blockquote></p><p> In the runup to its inclusion in the U.S. benchmark, Moderna’s stock has made fresh highs advancing more than 30% over four sessions before a 2% dip on Tuesday. Its shares closed 4.5% higher at $321.11, another record, with a market value of about $129 billion.</p><p><blockquote>在被纳入美国基准指数的前夕,Moderna 的股价屡创新高,在周二下跌 2% 之前,四个交易日上涨了 30% 以上。其股价收盘上涨4.5%,至321.11美元,再创历史新高,市值约为1290亿美元。</blockquote></p><p> Moderna’s rise has come largely from its innovations in developing messenger RNA vaccines, which use the body’s cells as mini vaccine factories. That has led some Wall Street analysts to call it the “Tesla of biotech” because the Cambridge, Massachusetts-based company is charting a course that may change the way infectious diseases are treated.</p><p><blockquote>Moderna 的崛起主要来自于其在开发信使 RNA 疫苗方面的创新,该疫苗利用人体细胞作为迷你疫苗工厂。这让一些华尔街分析师将其看涨期权为 “生物技术特斯拉”,因为这家总部位于马萨诸塞州剑桥市的公司正在规划一条可能改变传染病治疗方式的路线。</blockquote></p><p> The company secured its place in the upper echelons of U.S. biotechs next to AbbVie Inc. and Amgen Inc. -- after receiving emergency authorization for its Covid-19 vaccination last December, just a week behind Pfizer Inc. and BioNTech SE.</p><p><blockquote>该公司在去年 12 月获得 Covid-19 疫苗接种紧急授权后,仅落后辉瑞公司和 BioNTech SE 一周,从而确保了其在美国生物技术公司上层的地位,仅次于艾伯维公司和安进公司。</blockquote></p><p> But the parallels with Tesla don’t necessarily bode well for Moderna’s stock. Since the day before Tesla’s inclusion in the benchmark in December, it has fallen about 6% versus the index’s gain of nearly 18%. Other recent additions to the index have also underperformed.</p><p><blockquote>但与特斯拉的相似之处并不一定是 Moderna 股票的好兆头。自 12 月特斯拉被纳入基准指数的前一天以来,该指数已下跌约 6%,而该指数则上涨了近 18%。该指数最近添加的其他股票也表现不佳。</blockquote></p><p> Shares of companies entering the index typically rally ahead of the inclusion as investors adjust their portfolios. Moderna’s shares were already losing steam on Tuesday, closing 2% lower at $307.33.</p><p><blockquote>随着投资者调整投资组合,进入该指数的公司的股票通常会在纳入该指数之前上涨。周二,Moderna 的股价已经失去了动力,收盘下跌 2%,报 307.33 美元。</blockquote></p><p> Skeptics of Moderna’s surge in recent months note that its pipeline is in the early stages of human testing while the market for Covid-19 booster shots isn’t yet fully understood.</p><p><blockquote>对 Moderna 近几个月来激增的怀疑论者指出,该公司的产品线正处于人体测试的早期阶段,而 Covid-19 加强注射的市场尚未完全了解。</blockquote></p><p> Still, recent lab results show Moderna’s jab produces antibodies against the Covid-19 Delta variant. Analysts at Goldman Sachs also predict Moderna could have a new flu shot on the market by 2023 and a combination of a flu and Covid-19 vaccine as soon as 2024. The company also is working on new vaccines and medicines for cancer and HIV as well as Zika and heart disease.</p><p><blockquote>尽管如此,最近的实验室结果显示,Moderna 的疫苗能产生针对 Covid-19 德尔塔变异毒株的抗体。高盛分析师还预测,Moderna 可能会在 2023 年之前在市场上推出新的流感疫苗,最早可能在 2024 年推出流感和 Covid-19 疫苗的组合。该公司还致力于癌症和艾滋病毒以及寨卡病毒和心脏病的新疫苗和药物。</blockquote></p><p> A survey of 191 hedge funds and institutional investors from Jefferies trading desk indicated that roughly 73% of respondents expect Moderna shares to be little changed or to fall 20% or worse into year end. The investors were most keenly focused on a delta booster and flu shot results, while only 13% were long Moderna.</p><p><blockquote>Jefferies trading desk 对 191 家对冲基金和机构投资者进行的一项调查显示,大约 73% 的受访者预计 Moderna 股价到年底变化不大或下跌 20% 或更严重。投资者最关注的是 delta 加强剂和流感疫苗的结果,而只有 13% 的投资者做多 Moderna。</blockquote></p><p> “In the end, we still have no idea who is buying the stock,” Will Sevush, a strategist with Jefferies wrote to clients, “bulls are very few and very far between.”</p><p><blockquote>“杰富瑞(Jefferies)策略师威尔-塞武什(Will Sevush)在给客户的信中写道:”最终,我们仍然不知道谁在买这只股票,“多头很少,而且很少。”</blockquote></p><p> Sales of mRNA-1273, as Moderna’s Covid inoculation is called, are likely to beat Wall Street consensus for $18.1 billion in 2021, according to Goldman. But even the Wall Street high price target of $299 from Moderna’s biggest enthusiast -- Goldman analyst Salveen Richter -- implies further retreat.</p><p><blockquote>据高盛称,Moderna 公司的 Covid 疫苗名为 mRNA-1273,2021 年的销售额可能会超过华尔街共识的 181 亿美元。但即使是 Moderna 的最大爱好者--高盛分析师萨尔文-里希特(Salveen Richter)--提出的 299 美元的华尔街高目标价也意味着进一步回撤。</blockquote></p><p></p>","source":"lsy1612507957220","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Moderna Joins Top S&P 500 Firms as Stock Value Triples<blockquote>Moderna 加入标普500顶级公司行列,股票价值增加两倍</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nModerna Joins Top S&P 500 Firms as Stock Value Triples<blockquote>Moderna 加入标普500顶级公司行列,股票价值增加两倍</blockquote>\n</h2>\n<h4 class=\"meta\">\n<p class=\"head\">\n<strong class=\"h-name small\">Bloomberg</strong><span class=\"h-time small\">2021-07-22 10:43</span>\n</p>\n</h4>\n</header>\n<article>\n<p>(Bloomberg) -- Moderna Inc. joined the S&P 500 on Wednesday as the index’s the best performing stock this year -- by a mile.</p><p><blockquote>(彭博社) -- Moderna Inc. 周三加入标普500,成为该指数今年表现最好的股票。</blockquote></p><p> The move caps the drugmaker’s transformation from an early-stage biotech to a vaccine maker supplying Covid shots to the world. With a gain of just over 207% so far in 2021, Moderna’s share performance tops the index’s existing leader, L Brands Inc., which has risen about 104%.</p><p><blockquote>此举标志着该制药商从一家早期生物技术公司向一家向全球供应 Covid 疫苗的疫苗制造商的转型。2021 年迄今为止,Moderna 的股价涨幅略高于 207%,超过了该指数的现有领头羊 L Brands Inc.</blockquote></p><p> In the runup to its inclusion in the U.S. benchmark, Moderna’s stock has made fresh highs advancing more than 30% over four sessions before a 2% dip on Tuesday. Its shares closed 4.5% higher at $321.11, another record, with a market value of about $129 billion.</p><p><blockquote>在被纳入美国基准指数的前夕,Moderna 的股价屡创新高,在周二下跌 2% 之前,四个交易日上涨了 30% 以上。其股价收盘上涨4.5%,至321.11美元,再创历史新高,市值约为1290亿美元。</blockquote></p><p> Moderna’s rise has come largely from its innovations in developing messenger RNA vaccines, which use the body’s cells as mini vaccine factories. That has led some Wall Street analysts to call it the “Tesla of biotech” because the Cambridge, Massachusetts-based company is charting a course that may change the way infectious diseases are treated.</p><p><blockquote>Moderna 的崛起主要来自于其在开发信使 RNA 疫苗方面的创新,该疫苗利用人体细胞作为迷你疫苗工厂。这让一些华尔街分析师将其看涨期权为 “生物技术特斯拉”,因为这家总部位于马萨诸塞州剑桥市的公司正在规划一条可能改变传染病治疗方式的路线。</blockquote></p><p> The company secured its place in the upper echelons of U.S. biotechs next to AbbVie Inc. and Amgen Inc. -- after receiving emergency authorization for its Covid-19 vaccination last December, just a week behind Pfizer Inc. and BioNTech SE.</p><p><blockquote>该公司在去年 12 月获得 Covid-19 疫苗接种紧急授权后,仅落后辉瑞公司和 BioNTech SE 一周,从而确保了其在美国生物技术公司上层的地位,仅次于艾伯维公司和安进公司。</blockquote></p><p> But the parallels with Tesla don’t necessarily bode well for Moderna’s stock. Since the day before Tesla’s inclusion in the benchmark in December, it has fallen about 6% versus the index’s gain of nearly 18%. Other recent additions to the index have also underperformed.</p><p><blockquote>但与特斯拉的相似之处并不一定是 Moderna 股票的好兆头。自 12 月特斯拉被纳入基准指数的前一天以来,该指数已下跌约 6%,而该指数则上涨了近 18%。该指数最近添加的其他股票也表现不佳。</blockquote></p><p> Shares of companies entering the index typically rally ahead of the inclusion as investors adjust their portfolios. Moderna’s shares were already losing steam on Tuesday, closing 2% lower at $307.33.</p><p><blockquote>随着投资者调整投资组合,进入该指数的公司的股票通常会在纳入该指数之前上涨。周二,Moderna 的股价已经失去了动力,收盘下跌 2%,报 307.33 美元。</blockquote></p><p> Skeptics of Moderna’s surge in recent months note that its pipeline is in the early stages of human testing while the market for Covid-19 booster shots isn’t yet fully understood.</p><p><blockquote>对 Moderna 近几个月来激增的怀疑论者指出,该公司的产品线正处于人体测试的早期阶段,而 Covid-19 加强注射的市场尚未完全了解。</blockquote></p><p> Still, recent lab results show Moderna’s jab produces antibodies against the Covid-19 Delta variant. Analysts at Goldman Sachs also predict Moderna could have a new flu shot on the market by 2023 and a combination of a flu and Covid-19 vaccine as soon as 2024. The company also is working on new vaccines and medicines for cancer and HIV as well as Zika and heart disease.</p><p><blockquote>尽管如此,最近的实验室结果显示,Moderna 的疫苗能产生针对 Covid-19 德尔塔变异毒株的抗体。高盛分析师还预测,Moderna 可能会在 2023 年之前在市场上推出新的流感疫苗,最早可能在 2024 年推出流感和 Covid-19 疫苗的组合。该公司还致力于癌症和艾滋病毒以及寨卡病毒和心脏病的新疫苗和药物。</blockquote></p><p> A survey of 191 hedge funds and institutional investors from Jefferies trading desk indicated that roughly 73% of respondents expect Moderna shares to be little changed or to fall 20% or worse into year end. The investors were most keenly focused on a delta booster and flu shot results, while only 13% were long Moderna.</p><p><blockquote>Jefferies trading desk 对 191 家对冲基金和机构投资者进行的一项调查显示,大约 73% 的受访者预计 Moderna 股价到年底变化不大或下跌 20% 或更严重。投资者最关注的是 delta 加强剂和流感疫苗的结果,而只有 13% 的投资者做多 Moderna。</blockquote></p><p> “In the end, we still have no idea who is buying the stock,” Will Sevush, a strategist with Jefferies wrote to clients, “bulls are very few and very far between.”</p><p><blockquote>“杰富瑞(Jefferies)策略师威尔-塞武什(Will Sevush)在给客户的信中写道:”最终,我们仍然不知道谁在买这只股票,“多头很少,而且很少。”</blockquote></p><p> Sales of mRNA-1273, as Moderna’s Covid inoculation is called, are likely to beat Wall Street consensus for $18.1 billion in 2021, according to Goldman. But even the Wall Street high price target of $299 from Moderna’s biggest enthusiast -- Goldman analyst Salveen Richter -- implies further retreat.</p><p><blockquote>据高盛称,Moderna 公司的 Covid 疫苗名为 mRNA-1273,2021 年的销售额可能会超过华尔街共识的 181 亿美元。但即使是 Moderna 的最大爱好者--高盛分析师萨尔文-里希特(Salveen Richter)--提出的 299 美元的华尔街高目标价也意味着进一步回撤。</blockquote></p><p></p>\n<div class=\"bt-text\">\n\n\n<p> 来源:<a href=\"https://finance.yahoo.com/news/moderna-joins-top-firms-p-110555617.html\">Bloomberg</a></p>\n<p>为提升您的阅读体验,我们对本页面进行了排版优化</p>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"MRNA":"Moderna, Inc."},"source_url":"https://finance.yahoo.com/news/moderna-joins-top-firms-p-110555617.html","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1105130573","content_text":"(Bloomberg) -- Moderna Inc. joined the S&P 500 on Wednesday as the index’s the best performing stock this year -- by a mile.\nThe move caps the drugmaker’s transformation from an early-stage biotech to a vaccine maker supplying Covid shots to the world. With a gain of just over 207% so far in 2021, Moderna’s share performance tops the index’s existing leader, L Brands Inc., which has risen about 104%.\nIn the runup to its inclusion in the U.S. benchmark, Moderna’s stock has made fresh highs advancing more than 30% over four sessions before a 2% dip on Tuesday. Its shares closed 4.5% higher at $321.11, another record, with a market value of about $129 billion.\nModerna’s rise has come largely from its innovations in developing messenger RNA vaccines, which use the body’s cells as mini vaccine factories. That has led some Wall Street analysts to call it the “Tesla of biotech” because the Cambridge, Massachusetts-based company is charting a course that may change the way infectious diseases are treated.\nThe company secured its place in the upper echelons of U.S. biotechs next to AbbVie Inc. and Amgen Inc. -- after receiving emergency authorization for its Covid-19 vaccination last December, just a week behind Pfizer Inc. and BioNTech SE.\nBut the parallels with Tesla don’t necessarily bode well for Moderna’s stock. Since the day before Tesla’s inclusion in the benchmark in December, it has fallen about 6% versus the index’s gain of nearly 18%. Other recent additions to the index have also underperformed.\nShares of companies entering the index typically rally ahead of the inclusion as investors adjust their portfolios. Moderna’s shares were already losing steam on Tuesday, closing 2% lower at $307.33.\nSkeptics of Moderna’s surge in recent months note that its pipeline is in the early stages of human testing while the market for Covid-19 booster shots isn’t yet fully understood.\nStill, recent lab results show Moderna’s jab produces antibodies against the Covid-19 Delta variant. Analysts at Goldman Sachs also predict Moderna could have a new flu shot on the market by 2023 and a combination of a flu and Covid-19 vaccine as soon as 2024. The company also is working on new vaccines and medicines for cancer and HIV as well as Zika and heart disease.\nA survey of 191 hedge funds and institutional investors from Jefferies trading desk indicated that roughly 73% of respondents expect Moderna shares to be little changed or to fall 20% or worse into year end. The investors were most keenly focused on a delta booster and flu shot results, while only 13% were long Moderna.\n“In the end, we still have no idea who is buying the stock,” Will Sevush, a strategist with Jefferies wrote to clients, “bulls are very few and very far between.”\nSales of mRNA-1273, as Moderna’s Covid inoculation is called, are likely to beat Wall Street consensus for $18.1 billion in 2021, according to Goldman. But even the Wall Street high price target of $299 from Moderna’s biggest enthusiast -- Goldman analyst Salveen Richter -- implies further retreat.","news_type":1,"symbols_score_info":{"MRNA":0.9}},"isVote":1,"tweetType":1,"viewCount":1512,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":176856645,"gmtCreate":1626877125087,"gmtModify":1633770176009,"author":{"id":"3585284420886130","authorId":"3585284420886130","name":"LancetAeon","avatar":"https://static.tigerbbs.com/dee20d63780d522a952021ff6acccef1","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3585284420886130","authorIdStr":"3585284420886130"},"themes":[],"title":"","htmlText":"I like reading variable article please it’s no good ","listText":"I like reading variable article please it’s no good ","text":"I like reading variable article please it’s no good","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/176856645","repostId":"1107219983","repostType":4,"isVote":1,"tweetType":1,"viewCount":1495,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":171008821,"gmtCreate":1626693005163,"gmtModify":1633924901440,"author":{"id":"3585284420886130","authorId":"3585284420886130","name":"LancetAeon","avatar":"https://static.tigerbbs.com/dee20d63780d522a952021ff6acccef1","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3585284420886130","authorIdStr":"3585284420886130"},"themes":[],"title":"","htmlText":"Thanks good great appreciates ","listText":"Thanks good great appreciates ","text":"Thanks good great appreciates","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/171008821","repostId":"1131398390","repostType":4,"isVote":1,"tweetType":1,"viewCount":1689,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":113003232,"gmtCreate":1622576437026,"gmtModify":1634100364119,"author":{"id":"3585284420886130","authorId":"3585284420886130","name":"LancetAeon","avatar":"https://static.tigerbbs.com/dee20d63780d522a952021ff6acccef1","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3585284420886130","authorIdStr":"3585284420886130"},"themes":[],"title":"","htmlText":"Don’t be like this . Too good ","listText":"Don’t be like this . Too good ","text":"Don’t be like this . Too good","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/113003232","repostId":"2140460638","repostType":4,"isVote":1,"tweetType":1,"viewCount":2503,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":113003863,"gmtCreate":1622576370452,"gmtModify":1634100364242,"author":{"id":"3585284420886130","authorId":"3585284420886130","name":"LancetAeon","avatar":"https://static.tigerbbs.com/dee20d63780d522a952021ff6acccef1","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3585284420886130","authorIdStr":"3585284420886130"},"themes":[],"title":"","htmlText":"Commenting here for comments","listText":"Commenting here for comments","text":"Commenting here for comments","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/113003863","repostId":"2140989404","repostType":4,"isVote":1,"tweetType":1,"viewCount":1740,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"defaultTab":"following","isTTM":false}